SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-05-051054
Filing Date
2005-03-15
Accepted
2005-03-15 16:13:26
Documents
9
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT d10k.htm 10-K 1047909
2 FORM NOTICE OF GRANT AND STOCK OPTION AGREEMENT dex1011.htm EX-10.11 41792
3 FORM OF NOTICE OF GRANT AND STOCK OPTION AGREEMENT dex1012.htm EX-10.12 39244
4 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 1760
5 CEO CERTIFICATION PURSUANT TO RULE 13A-14(A) dex311.htm EX-31.1 9756
6 CFO CERTIFICATION PURSUANT TO RULE 13A-14(A) dex312.htm EX-31.2 9754
7 CEO CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 dex321.htm EX-32.1 3936
8 CFO CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 dex322.htm EX-32.2 3885
9 GRAPHIC g28056g67k80.jpg GRAPHIC 20437
  Complete submission text file 0001193125-05-051054.txt   1181172
Mailing Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021
Business Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021 4255274000
SEATTLE GENETICS INC /WA (Filer) CIK: 0001060736 (see all company filings)

IRS No.: 911874389 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-32405 | Film No.: 05681889
SIC: 2836 Biological Products, (No Diagnostic Substances)